Search Results - "TAKAMOTO, HITOSHI"

Refine Results
  1. 1

    Early Experiences of Contact Laser Vaporization of the Prostate using the 980 nm High Power Diode Laser for Benign Prostatic Hyperplasia by MIYAZAKI, Hideyo, HIRANO, Yoshikazu, KATO, Shinobu, IORITANI, Naomasa, ICHIKAWA, Takaharu, TAKAMOTO, Hitoshi, HOMMA, Yukio

    Published in Lower urinary tract symptoms (01-09-2018)
    “…Objectives We report early experiences of contact laser vaporization of the prostate for symptomatic benign prostatic hyperplasia (BPH). Methods A total of 80…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Early Experiences of Contact Laser Vaporization of the Prostate using the 980nm High Power Diode Laser for Benign Prostatic Hyperplasia by MIYAZAKI, Hideyo, HIRANO, Yoshikazu, KATO, Shinobu, IORITANI, Naomasa, ICHIKAWA, Takaharu, TAKAMOTO, Hitoshi, HOMMA, Yukio

    Published in Lower urinary tract symptoms (01-09-2018)
    “…ObjectivesWe report early experiences of contact laser vaporization of the prostate for symptomatic benign prostatic hyperplasia (BPH).MethodsA total of 80…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: A prospective, randomized controlled study by YOKOYAMA, TERUHIKO, KUMON, HIROMI, NASU, YOSHITSUGU, TAKAMOTO, HITOSHI, WATANABE, TOYOHIKO

    Published in International journal of urology (01-07-2006)
    “…Background:  The present study investigated the efficacy, safety, and utility of starting an α1d‐selective antagonist, naftopidil, at 75 or 25 mg/day in…”
    Get full text
    Journal Article
  9. 9

    Twelve Months Follow-up of Injection of OnabotulinumtoxinA into Vesical Submucosa for Refractory Non-neurogenic Overactive Bladder by OKAMURA, Kikuo, TAKEI, Mineo, NOJIRI, Yoshikatsu, OTSUKA, Atsushi, TAKAMOTO, Hitoshi, MAEDA, Yoshiko, FUJIMURA, Tetsuya, YOKOYAMA, Teruhiko, GOTOH, Momokazu, HOMMA, Yukio

    Published in Lower urinary tract symptoms (01-05-2013)
    “…Objective: The aim of the present study was to assess the effects of onabotulinumtoxinA injection for refractory non‐neurogenic overactive bladder (OAB) for 12…”
    Get full text
    Journal Article
  10. 10

    Prostate specific antigen complexed to α‐1‐antichymotrypsin in patients with intermediate prostate specific antigen levels by Saika, Takashi, Tsushima, Tomoyasu, Nasu, Yasutomo, Kusaka, Nobuyuki, Miyaji, Yoshiyuki, Takamoto, Hitoshi, Takeda, Katsuji, Uno, Satoru, Kumon, Hiromi

    Published in Cancer (15-03-2002)
    “…BACKGROUND The authors attempted to evaluate prospectively the usefulness of serum prostate specific antigen (PSA) complexed to α‐1‐antichymotrypsin (PSA‐ACT)…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder in Japanese patients by TAKEI, MINEO, HOMMA, YUKIO

    Published in International journal of urology (01-05-2005)
    “…Aim: To evaluate the long‐term safety, tolerability and efficacy of extended‐release (ER) tolterodine in Japanese patients completing 12‐week treatment in a…”
    Get full text
    Journal Article
  15. 15

    Prophylactic intravesical instillation therapy in patients with superficial bladder cancer--results of a randomized prospective study by Tsushima, T, Nasu, Y, Abeki, N, Noda, M, Saika, T, Ohmori, H, Kobashi, K, Ozaki, Y, Matsumura, Y, Tanahashi, T

    Published in Nippon Hinyokika Gakkai zasshi (01-08-1992)
    “…A randomized prospective study was conducted for the purpose of investigating the efficacy of intravesical chemoprophylaxis of superficial bladder cancers…”
    Get more information
    Journal Article
  16. 16

    STUDIES OF FOSFOMYCIN FOR INTRAVENOUS INJECTION IN URINARY TRACT INFECTIONS by KONDO, KATSUYOSHI, TAKAMOTO, HITOSHI, NIIJIMA, TADAO

    Published in CHEMOTHERAPY (1975)
    “…1) Minimal inhibitory concentration of fosfomycin was determined on 94 strains isolated from urinary tract infections by the plate dilution method. Most…”
    Get full text
    Journal Article
  17. 17

    LABORATORY AND CLINICAL STUDIES ON CARFECILLIN IN CHRONIC URINARY TRACT INFECTIONS by TAKAMOTO, HITOSHI, KONDO, KATSUYOSHI, NIIJIMA, TADAO

    Published in CHEMOTHERAPY (1975)
    “…1) In one case with normal renal function, the serum level of CBPC reached to the maximum (5.9μg/ ml) at one hour after oral administration of carfecillin 1.0…”
    Get full text
    Journal Article
  18. 18

    EXPERIMENTAL AND CLINICAL STUDIES ON TOBRAMYCIN IN COMPLICATED URINARY TRACT INFECTIONS by KONDO, KATSUYOSHI, TAKAMOTO, HITOSHI, NIIJIMA, TADAO

    Published in CHEMOTHERAPY (1975)
    “…1) Minimal inhibitory concentration of tobramycin was determined on 101 strains isolated from urinary tract infections by the plate dilution method. All…”
    Get full text
    Journal Article
  19. 19

    EXPERIMENTAL AND CLINICAL STUDIES ON CARBENICILLIN INDANYL SODIUM IN URINARY TRACT INFECTIONS by KONDO, KATSUYOSHI, TAKAMOTO, HITOSHI, NIIJIMA, TADAO

    Published in CHEMOTHERAPY (1975)
    “…1) Minimal inhibitory concentration of carbenicillin indanyl sodium (I-CBPC) was determined on 88 strains isolated from urinary tract infections by the plate…”
    Get full text
    Journal Article
  20. 20

    STUDIES ON CEPHRADINE IN URINARY TRACT INFECTIONS by KONDO, KATSUYOSHI, TAKAMOTO, HITOSHI, NIIJIMA, TADAO

    Published in CHEMOTHERAPY (1975)
    “…1) Minimal inhibitory concentration of cephradine was determined by the plate dilution method on 100 strains isolated from urinary tract infections. All…”
    Get full text
    Journal Article